Bamco Inc Alector, Inc. Transaction History

Bamco Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$19.35 - $25.54 $13,545 - $17,878	-700 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$15.5 - $22.48 $358,081 - $519,332	-23,102 Reduced 97.06%	700 $15,000
Q1 2021 May 19, 2021	SELL	$14.84 - $22.23 $11,174 - $16,739	-753 Reduced 3.07%	23,802 $479,000
Q4 2020 Feb 12, 2021	SELL	$9.4 - $16.7 $43,418 - $77,137	-4,619 Reduced 15.83%	24,555 $372,000
Q3 2020 Nov 13, 2020	SELL	$10.54 - $24.96 $4.61 Million - $10.9 Million	-437,786 Reduced 93.75%	29,174 $307,000
Q2 2020 Aug 14, 2020	BUY	$21.87 - $33.11 $45,927 - $69,531	2,100 Added 0.45%	466,960 $11.4 Million
Q1 2020 May 15, 2020	SELL	$16.25 - $35.28 $136,500 - $296,352	-8,400 Reduced 1.77%	464,860 $11.2 Million
Q4 2019 Feb 18, 2020	SELL	$14.17 - $20.3 $246,175 - $352,671	-17,373 Reduced 3.54%	473,260 $8.15 Million
Q3 2019 Nov 14, 2019	BUY	$14.42 - $22.2 $3.56 Million - $5.48 Million	246,846 Added 101.25%	490,633 $7.08 Million
Q2 2019 Aug 15, 2019	BUY	$16.26 - $26.42 $3.96 Million - $6.44 Million	243,787 New	243,787 $4.63 Million

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.